摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-[4-(2-Fluorobenzoyl)-1-piperazinyl]-8-nitroquinoline

中文名称
——
中文别名
——
英文名称
5-[4-(2-Fluorobenzoyl)-1-piperazinyl]-8-nitroquinoline
英文别名
(2-fluorophenyl)-[4-(8-nitroquinolin-5-yl)piperazin-1-yl]methanone
5-[4-(2-Fluorobenzoyl)-1-piperazinyl]-8-nitroquinoline化学式
CAS
——
化学式
C20H17FN4O3
mdl
MFCD02070660
分子量
380.4
InChiKey
SWGLCSKVQGGDNQ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.2
  • 重原子数:
    28
  • 可旋转键数:
    2
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.2
  • 拓扑面积:
    82.3
  • 氢给体数:
    0
  • 氢受体数:
    6

文献信息

  • Compositions and methods for modulating interaction between polypeptides
    申请人:Kazantsev G. Aleksey
    公开号:US20050239833A1
    公开(公告)日:2005-10-27
    The present invention is based, in part, on assays we conducted that revealed compounds that may be used to treat or prevent diseases characterized by an abnormal or undesirable association of one protein with another.
    本发明部分基于我们所进行的检测,这些检测揭示了可用于治疗或预防以一种蛋白质与另一种蛋白质的异常或不良结合为特征的疾病的化合物。
  • COMPOSITIONS AND METHODS FOR MODULATING INTERACTION BETWEEN POLYPEPTIDES
    申请人:The General Hospital Corporation
    公开号:US20130203733A1
    公开(公告)日:2013-08-08
    The present invention is based, in part, on assays we conducted that revealed compounds that may be used to treat or prevent diseases characterized by an abnormal or undesirable association of one protein with another.
  • Sirtuin Modulators as Inhibitors of Cytomegalovirus
    申请人:The Trustees of Princeton University
    公开号:US20160296523A1
    公开(公告)日:2016-10-13
    Agents and methods of inhibiting or improving the growth of viruses are provided.
  • US8404747B2
    申请人:——
    公开号:US8404747B2
    公开(公告)日:2013-03-26
  • [EN] COMPOSITIONS AND METHODS FOR MODULATING INTERACTION BETWEEN POLYPEPTIDES<br/>[FR] COMPOSITIONS ET PROCEDES POUR MODULER L'INTERACTION ENTRE DES POLYPEPTIDES
    申请人:GEN HOSPITAL CORP
    公开号:WO2005087217A1
    公开(公告)日:2005-09-22
    The present invention is based, in part, on assays we conducted that revealed compounds that may be used to treat or prevent diseases characterized by an abnormal or undesirable association of one protein with another.
查看更多